Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Cardiotoxicity 1

Interventions

Trastuzumab 8 Doxorubicin 8 Exercise 6 Cyclophosphamide 6 Echocardiography 5 Carvedilol 5 Docetaxel 4 Tablets 2 Silymarin 2 Radiotherapy 2 Paclitaxel 2 Magnetic Resonance Spectroscopy 2 Exercise Test 2 Epirubicin 2 Bisoprolol 2 Atorvastatin 2 Anthracyclines 2 sacubitril and valsartan sodium hydrate drug combination 1 nicotinamide-beta-riboside 1 mitoquinone 1 epicatechin gallate 1 empagliflozin 1 dapagliflozin 1 candesartan 1 Watchful Waiting 1 Therapeutics 1 Taxes 1 Tamoxifen 1 Social Determinants of Health 1 Secondary Prevention 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Cardiotoxicity × Rosuvastatin Calcium × Breast × Clear all

NCT07254221 2025-12-10

ROSUBREAST

Shiraz University of Medical Sciences

Phase 4 Not yet recruiting

Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡